Mednax Inc $ 23.76 0.63 (2.72%)
On watch
Volume:
178,171
Avg Vol (1m):
867,964
Market Cap $:
2.01 Bil
Enterprise Value $:
4.07 Bil
P/E (TTM):
10.39
P/B:
0.75
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $23.76 | ||
Manual of Stocks™ Web
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.05 | ||
| Equity-to-Asset | 0.48 | ||
| Debt-to-Equity | 0.8 | ||
| Debt-to-EBITDA | 4.39 | ||
| Interest Coverage | 3.41 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 1.78 | ||
| Beneish M-Score | -2.95 | ||
| WACC vs ROIC | |||
Profitability | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 10.47 | ||
| Net Margin % | -3.53 | ||
| ROE % | -4.24 | ||
| ROA % | -2.16 | ||
| ROC (Joel Greenblatt) % | 87.74 | ||
| 3-Year Revenue Growth Rate | 10.4 | ||
| 3-Year EBITDA Growth Rate | -2.4 | ||
| 3-Year EPS without NRI Growth Rate | -6.5 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 6.39 | ||
| PE Ratio without NRI | 10.39 | ||
| PB Ratio | 0.75 | ||
| PS Ratio | 0.6 | ||
| Price-to-Free-Cash-Flow | 7.38 | ||
| Price-to-Operating-Cash-Flow | 6.35 | ||
| EV-to-EBIT | 10.62 | ||
| EV-to-EBITDA | 8.23 | ||
| EV-to-Revenue | 1.15 | ||
| PEG Ratio | 2 | ||
| Shiller PE Ratio | 8.91 | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.23 | ||
| Days Sales Outstanding | 51.86 | ||
| Days Payable | 4.5 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.3 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 0.81 | ||
| Price-to-Median-PS-Value | 0.28 | ||
| Earnings Yield (Greenblatt) % | 9.39 | ||
| Forward Rate of Return (Yacktman) % | 19.51 |